Cargando…
Genomic Analysis of Glioblastoma Multiforme Reveals a Key Transcription Factor Signature Relevant to Prognosis and the Immune Processes
INTRODUCTION: Glioblastoma multiforme (GBM) develops through the accumulation of both genetic and expression alterations. Although many gene signatures have been developed as prognostic and predictive biomarkers, their robustness and functional aspects are less well characterized. The expression of...
Autores principales: | Li, Zhen-Hang, Guan, Yan-Lei, Zhang, Guo-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112242/ https://www.ncbi.nlm.nih.gov/pubmed/33987093 http://dx.doi.org/10.3389/fonc.2021.657531 |
Ejemplares similares
-
Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022) -
M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020) -
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
por: Chin, Christopher, et al.
Publicado: (2018) -
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019) -
Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme
por: Han, Xudong, et al.
Publicado: (2020)